This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by King, D.J. Articles by Yisak, W. Search for Related Content PubMed Articles by King, D.J. Articles by Yisak, W. Social Bookmarking                         What's this?

The effects of remoxipride and chlorpromazine on eye movements and psychomotor performance in healthy volunteers

Department of Therapeutics and Pharmacology, The Queen's University of Belfast

P. Best

Department of Therapeutics and Pharmacology, The Queen's University of Belfast

G. Lynch

Department of Therapeutics and Pharmacology, The Queen's University of Belfast

M.F. Mannion

Holywell Hospital, Antrim, Northern Ireland

R.C. Montgomery

Department of Therapeutics and Pharmacology, The Queen's University of Belfast

B. Tiplady

Astra Clinical Research Unit, Edinburgh, UK

W. Yisak

Astra Arcus, Södertälje, Sweden

Fifteen healthy male volunteers received single doses of 100 mg immediate release remoxipride (IR), 150 mg controlled release remoxipride (CR), 50 mg chlorpromazine (CPZ), 2 mg lorazepam (LZ), and placebo in a randomised, five-period cross-over study. Both saccadic (SEM) and smooth pursuit eye movements (SPEM) as well as a battery of psychomotor performance tests were assessed at 1.5-h intervals over 9 h following drug administration. The areas under the response-time curves and the maximum effect during the study period were analysed by analysis of variance. The most consistent impairments were produced by LZ. The neuroleptics caused impairments to SEM, and tended to impair critical flicker fusion, continuous attention and both paced and unpaced versions of the digit-symbol substitution test as well as subjective measures of sedation. Only LZ impaired SPEM. Neither paced nor unpaced psychomotor tests distinguished between neuroleptics and benzodiazepines. The low therapeutic doses of IR and CR produced similar impairments to a sub-therapeutic dose of CPZ. Selectivity of pharmacological action does not appear to predict selectivity of effect on psychomotor function.

Key Words: remoxipride • neuroleptics • eye movements • psychomotor performance • attention

Journal of Psychopharmacology, Vol. 9, No. 2, 143-149 (1995)
DOI: 10.1177/026988119500900209


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Legangneux, J. McEwen, K. A. Wesnes, L. Bergougnan, N. Miget, M. Canal, C. L'Heritier, J. L. Pinquier, and P. Rosenzweig The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers J Psychopharmacol, March 1, 2000; 14(2): 164 - 171. [Abstract] [PDF]